Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cindy L O'Bryant

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 23, 2008
Screening and management of osteoporosis in breast cancer patients on aromatase inhibitorsKelli Gibson, Cindy L O'Bryant
Journal of the American Pharmacists Association : Japha|October 2, 2008
Community pharmacists' knowledge of and attitudes toward oral chemotherapyCindy L O'Bryant, Brian C Crandell
The Annals of Pharmacotherapy|November 22, 2013
Vismodegib: an inhibitor of the Hedgehog signaling pathway in the treatment of basal cell carcinomaAmber E Proctor, Lisa A Thompson, Cindy L O'Bryant
Pharmacotherapy|July 29, 2008
Bicalutamide-associated fulminant hepatotoxicityCindy L O'Bryant, Thomas W Flaig, Kenneth J Utz
The Annals of Pharmacotherapy|February 7, 2013
Crizotinib: a new treatment option for ALK-positive non-small cell lung cancerCindy L O'Bryant, Sarah D Wenger, Miryoung Kim, et al.
Expert Review of Anticancer Therapy|September 24, 2023
The emergence of targeted therapy for HER2-low triple-negative breast cancer: a review of fam-trastuzumab deruxtecanAnna R Schreiber, Cindy L O'Bryant, Peter Kabos, et al.
Critical Reviews in Oncology/Hematology|October 25, 2011
The intersection between cannabis and cancer in the United StatesDaniel W Bowles, Cindy L O'Bryant, D Ross Camidge, et al.
The Annals of Pharmacotherapy|September 13, 2012
Romidepsin: a histone deacetylase inhibitor for refractory cutaneous T-cell lymphomaMiryoung Kim, Lisa A Thompson, Sarah D Wenger, et al.
The Annals of Pharmacotherapy|September 6, 2012
Everolimus: a new treatment option for advanced pancreatic neuroendocrine tumorsLisa A Thompson, Miryoung Kim, Sarah D Wenger, et al.
Journal of Pain & Palliative Care Pharmacotherapy|September 20, 2011
Inconsistencies in opioid equianalgesic ratios: clinical and research implicationsCindy L O'Bryant, Sunny A Linnebur, Traci E Yamashita, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 23, 2008
Screening and management of osteoporosis in breast cancer patients on aromatase inhibitorsKelli Gibson, Cindy L O'Bryant
Journal of the American Pharmacists Association : Japha|October 2, 2008
Community pharmacists' knowledge of and attitudes toward oral chemotherapyCindy L O'Bryant, Brian C Crandell
The Annals of Pharmacotherapy|November 22, 2013
Vismodegib: an inhibitor of the Hedgehog signaling pathway in the treatment of basal cell carcinomaAmber E Proctor, Lisa A Thompson, Cindy L O'Bryant
Pharmacotherapy|July 29, 2008
Bicalutamide-associated fulminant hepatotoxicityCindy L O'Bryant, Thomas W Flaig, Kenneth J Utz
The Annals of Pharmacotherapy|February 7, 2013
Crizotinib: a new treatment option for ALK-positive non-small cell lung cancerCindy L O'Bryant, Sarah D Wenger, Miryoung Kim, et al.
Expert Review of Anticancer Therapy|September 24, 2023
The emergence of targeted therapy for HER2-low triple-negative breast cancer: a review of fam-trastuzumab deruxtecanAnna R Schreiber, Cindy L O'Bryant, Peter Kabos, et al.
Critical Reviews in Oncology/Hematology|October 25, 2011
The intersection between cannabis and cancer in the United StatesDaniel W Bowles, Cindy L O'Bryant, D Ross Camidge, et al.
The Annals of Pharmacotherapy|September 13, 2012
Romidepsin: a histone deacetylase inhibitor for refractory cutaneous T-cell lymphomaMiryoung Kim, Lisa A Thompson, Sarah D Wenger, et al.
The Annals of Pharmacotherapy|September 6, 2012
Everolimus: a new treatment option for advanced pancreatic neuroendocrine tumorsLisa A Thompson, Miryoung Kim, Sarah D Wenger, et al.
Journal of Pain & Palliative Care Pharmacotherapy|September 20, 2011
Inconsistencies in opioid equianalgesic ratios: clinical and research implicationsCindy L O'Bryant, Sunny A Linnebur, Traci E Yamashita, et al.
Pageof 5